Fortrea Announces Date for First Quarter 2026 Financial Results and Conference Call
Fortrea (Nasdaq: FTRE) will release its first quarter 2026 financial results before the market opens on Tuesday, May 5, 2026.
Rhea-AI Summary
Fortrea (Nasdaq: FTRE) will release its first quarter 2026 financial results before the market opens on Tuesday, May 5, 2026.
The company will host a conference call at 8:00 a.m. ET that day; participants should pre-register to receive dial-in details and a unique PIN. A live webcast will be available at investors.fortrea.com, with a replay posted in Events and Presentations after the call.
Details
News Market Reaction – FTRE
On Apr 21, the day this news came out, FTRE closed 1.15% below the previous close.
Data tracked by StockTitan Argus for the Apr 21 session.
Key Figures
- Q4 2025 revenue
- $660.5M
- Fourth quarter 2025 results
- FY 2025 revenue
- $2,723.4M
- Full-year 2025 results
- FY 2025 GAAP net loss
- $(986.2M)
- Full-year 2025, includes goodwill impairment
- Goodwill impairment
- $797.9M
- Recorded in H1 2025
- Backlog
- $7,728.0M
- Trailing-12-month book-to-bill 1.02x
- 2026 revenue guidance
- $2,550M–$2,650M
- Full-year 2026 outlook
- 2026 adj. EBITDA guide
- $190M–$220M
- Full-year 2026 outlook
- Conference call time
- 8:00 a.m. ET
- Q1 2026 results call on May 5, 2026
Previous Conferences,earnings date Reports
-
Announced Q4 and full-year 2025 results date and conference call details.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Key Terms
contract research organization (CRO) medical
AI-generated analysis. How Rhea-AI works. Not financial advice.
DURHAM, N.C., April 21, 2026 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE) (the “Company”), a leading global contract research organization (CRO), today announced that it will release its first quarter 2026 financial results before the market opens on Tuesday, May 5, 2026. The Company will host a conference call at 8:00 a.m. ET on that day to discuss the results.
To participate in the conference call, participants should pre-register via the call registration link. All registrants will receive dial-in details and a unique PIN providing access to the live call. To avoid potential delays, participants are encouraged to join at least 10 minutes prior to the start of the call.
The live webcast can be accessed at investors.fortrea.com. A replay will be available in the Events and Presentations section of the site following the conclusion of the call.
About Fortrea
Fortrea (Nasdaq: FTRE) is a leading global provider of clinical development solutions to the life sciences industry. We partner with emerging and large biopharmaceutical, biotechnology, medical device and diagnostic companies to drive healthcare innovation that accelerates life changing therapies to patients. Fortrea provides phase I-IV clinical trial management, clinical pharmacology and consulting services. Fortrea’s solutions leverage three decades of experience spanning more than 20 therapeutic areas, a passion for scientific rigor, exceptional insights and a strong investigator site network. Our talented and diverse team, operating across approximately 100 countries, is scaled to deliver focused, agile solutions to clients globally. Learn more about how Fortrea is streamlining drug development at Fortrea.com and follow us on LinkedIn, X and Bluesky.
Fortrea Contacts
Tracy Krumme (Investors) – 984-385-6707, tracy.krumme@fortrea.com
Sue Zaranek (Media) – 919-943-5422, media@fortrea.com
Kate Dillon (Media) – 646-818-9115, kdillon@prosek.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.